Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+1.29%	+4.22%	+39.99%	-0.83%	82.54B
MODERNA, INC.	+12.23%	+126.07%	+445.94%	+28.87%	53.23B
CSL LIMITED	-1.69%	+23.30%	-25.53%	-36.93%	58.38B
SAMSUNG BIOLOGICS CO.,LTD.	+1.94%	+0.64%	+0.46%	+32.78%	52.24B
UCB	+0.87%	+3.63%	+10.55%	+169.94%	48.52B
BIOGEN INC.	+0.94%	+2.77%	+55.00%	-18.65%	31.67B
INCYTE CORPORATION	+0.22%	+5.93%	+47.11%	+96.19%	25.79B
INNOVENT BIOLOGICS, INC.	+1.19%	+9.17%	+3.12%	+228.73%	22.46B
SWEDISH ORPHAN BIOVITRUM AB	-0.09%	+4.68%	+61.19%	+124.66%	16.91B
Average	+1.73%	+17.01%	+70.87%	+69.42%	43.53B
Weighted average by Cap.	+2.25%	+20.07%	+76.95%	+46.99%

Employees

Sector